DE69231291T2 - Impfsystem mit einer einzeldosis - Google Patents

Impfsystem mit einer einzeldosis

Info

Publication number
DE69231291T2
DE69231291T2 DE69231291T DE69231291T DE69231291T2 DE 69231291 T2 DE69231291 T2 DE 69231291T2 DE 69231291 T DE69231291 T DE 69231291T DE 69231291 T DE69231291 T DE 69231291T DE 69231291 T2 DE69231291 T2 DE 69231291T2
Authority
DE
Germany
Prior art keywords
pct
water
biologically active
active material
implantation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69231291T
Other languages
English (en)
Other versions
DE69231291D1 (de
Inventor
George Barr
James Thiel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Ltd
Monash University
Original Assignee
CSL Ltd
Monash University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CSL Ltd, Monash University filed Critical CSL Ltd
Publication of DE69231291D1 publication Critical patent/DE69231291D1/de
Application granted granted Critical
Publication of DE69231291T2 publication Critical patent/DE69231291T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
DE69231291T 1991-03-26 1992-03-25 Impfsystem mit einer einzeldosis Expired - Fee Related DE69231291T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPK526891 1991-03-26
PCT/AU1992/000124 WO1992017165A1 (en) 1991-03-26 1992-03-25 A single dose vaccination system

Publications (2)

Publication Number Publication Date
DE69231291D1 DE69231291D1 (de) 2000-08-31
DE69231291T2 true DE69231291T2 (de) 2001-01-18

Family

ID=3775296

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69231291T Expired - Fee Related DE69231291T2 (de) 1991-03-26 1992-03-25 Impfsystem mit einer einzeldosis

Country Status (8)

Country Link
US (1) US5593697A (de)
EP (1) EP0576522B1 (de)
AT (1) ATE194910T1 (de)
CA (1) CA2106952C (de)
DE (1) DE69231291T2 (de)
ES (1) ES2149174T3 (de)
NZ (2) NZ286242A (de)
WO (1) WO1992017165A1 (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
JP4129544B2 (ja) * 1993-03-29 2008-08-06 ファイザー・インク サポニンアジュバント使用の多成分系クロストリジウム・ワクチン
ES2183867T3 (es) * 1994-02-18 2003-04-01 Solidose L L C Inoculacion de animales con materiales biologicos secados en peletes.
US5980508A (en) * 1994-06-22 1999-11-09 Controlled Release Technologies Pty Ltd Controlled release device and method
FR2723536A1 (fr) * 1994-08-11 1996-02-16 Seth Pawan Composition permettant une liberation selective d'un principe actif
AUPM897594A0 (en) * 1994-10-25 1994-11-17 Daratech Pty Ltd Controlled release container
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
US6143037A (en) * 1996-06-12 2000-11-07 The Regents Of The University Of Michigan Compositions and methods for coating medical devices
US6140475A (en) * 1997-04-11 2000-10-31 Altus Biologics Inc. Controlled dissolution crosslinked protein crystals
DE69814122T2 (de) * 1997-10-09 2004-03-18 Dexcel Pharma Technologies Ltd. Darreichungsform zur verzögerten, vollständigen wirkstoffabgabe im verdauungstrakt
US6541606B2 (en) 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
PL343432A1 (en) * 1998-03-02 2001-08-13 Applied Vaccine Technologies C Methods and devices for modulating the immune response
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system
CA2351734A1 (en) 1998-11-20 2000-06-02 University Of Connecticut Generic integrated implantable potentiostat telemetry unit for electrochemical sensors
US20030099682A1 (en) * 1998-11-20 2003-05-29 Francis Moussy Apparatus and method for control of tissue/implant interactions
US20040121014A1 (en) * 1999-03-22 2004-06-24 Control Delivery Systems, Inc. Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
US7030097B1 (en) 1999-07-14 2006-04-18 Cornell Research Foundation, Inc. Controlled nucleic acid delivery systems
PT1212045T (pt) 1999-08-24 2016-11-22 Abic Biological Laboratories Ltd Composição de vacina e método de utilização da mesma
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
DE10035156A1 (de) * 2000-07-19 2002-02-07 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Proteinkomplex als Vehikel für oral verfügbare Protein-Arzneimittel
US7575780B2 (en) * 2000-08-07 2009-08-18 Orthogen Llc Method for manufacturing particles for use in forming a resorbable implant for stimulating bone growth
GB0025208D0 (en) * 2000-10-13 2000-11-29 Euro Celtique Sa Delayed release pharmaceutical formulations
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
DE60323482D1 (de) 2002-05-06 2008-10-23 Massachusetts Inst Technology Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken
US8871241B2 (en) * 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
US20050152939A1 (en) * 2002-05-22 2005-07-14 Bunt Craig R. Delivery technology
US20030224020A1 (en) * 2002-05-31 2003-12-04 Zabudkin Alexander F. Pharmaceutical preparation of botulinum neurotoxin, methods of synthesis and methods of clinical use
KR100628263B1 (ko) * 2002-08-21 2006-09-27 엘지.필립스 엘시디 주식회사 액정표시소자
US7452350B2 (en) * 2003-07-09 2008-11-18 Yeakley Rourke M Pre-dosed oral liquid medication dispensing system
PL2384753T3 (pl) 2003-08-29 2016-09-30 Pochodne hydantoiny jako inhibitory martwicy komórkowej
US20060280795A1 (en) * 2005-06-08 2006-12-14 Dexcel Pharma Technologies, Ltd. Specific time-delayed burst profile delivery system
AU2006282828B2 (en) 2005-08-23 2013-01-31 Smith & Nephew, Inc Telemetric orthopaedic implant
WO2007084587A2 (en) * 2006-01-20 2007-07-26 Monosol Rx, Llc Film lined pouch and method of manufacturing this pouch
WO2007103276A2 (en) * 2006-03-03 2007-09-13 Smith & Nephew, Inc. Systems and methods for delivering a medicament
CN101534799A (zh) * 2006-09-29 2009-09-16 莫诺索尔克斯有限公司 膜埋入式包装及其制备方法
WO2010075561A1 (en) 2008-12-23 2010-07-01 President And Fellows Of Harvard College Small molecule inhibitors of necroptosis
CA2785468A1 (en) * 2009-12-23 2011-06-30 Psivida Us, Inc. Sustained release delivery devices
US8109917B2 (en) * 2010-01-18 2012-02-07 Rourke M. Yeakley Twistable medication dispensing system
US8206368B2 (en) * 2010-01-18 2012-06-26 Rourke M. Yeakley Multi-chamber mixture dispensing system
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
US20140377320A1 (en) 2011-12-22 2014-12-25 Chuv, Centre Hospitalier Universitaire Vaudois Selective Plasma Activation for Medical Implants and Wound Healing Devices
ES2809713T3 (es) 2012-02-22 2021-03-05 Duchesnay Inc Formulación de doxilamina y piridoxina y/o metabolitos o sales de estas
US9717583B2 (en) 2014-03-13 2017-08-01 Cell and Molecular Tissue Engineering, LLC Sensors, cannulas, collars and coated surgical mesh, and corresponding systems and methods
US20160024098A1 (en) 2013-03-15 2016-01-28 President And Fellows Of Harvard College Hybrid necroptosis inhibitors
US10071199B2 (en) * 2013-03-15 2018-09-11 Incube Labs, Llc Multi-stage biodegradable drug delivery platform
TWI654977B (zh) 2013-07-22 2019-04-01 達契斯奈股份有限公司 用於控管噁心及嘔吐之組合物
CA2970525A1 (en) 2014-12-11 2016-06-16 President And Fellows Of Harvard College Inhibitors of cellular necrosis and related methods
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
KR20230137362A (ko) 2016-05-05 2023-10-04 어퀘스티브 테라퓨틱스, 아이엔씨. 강화된 전달 에프네프린 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
FR2454804B1 (fr) * 1979-04-26 1986-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
ZA86252B (en) * 1985-01-30 1986-09-24 Warner Lambert Co Coated dosage forms
EP0212745B1 (de) * 1985-08-16 1991-04-10 The Procter & Gamble Company Partikel mit konstanter Wirkstofffreisetzung
JPH0778017B2 (ja) * 1985-12-28 1995-08-23 住友製薬株式会社 パルス的かつ持続放出性製剤
EP0270575A4 (de) * 1986-05-16 1988-10-20 Victoria State Biocompatible implantate.
WO1990011070A1 (en) * 1989-03-17 1990-10-04 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
US5026559A (en) * 1989-04-03 1991-06-25 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
JPH03197421A (ja) * 1989-12-26 1991-08-28 Takeda Chem Ind Ltd 徐放性錠剤
US5091185A (en) * 1990-06-20 1992-02-25 Monsanto Company Coated veterinary implants

Also Published As

Publication number Publication date
US5593697A (en) 1997-01-14
NZ286242A (en) 1997-11-24
NZ242065A (en) 1996-06-25
CA2106952C (en) 2003-01-21
DE69231291D1 (de) 2000-08-31
WO1992017165A1 (en) 1992-10-15
CA2106952A1 (en) 1992-09-27
ES2149174T3 (es) 2000-11-01
EP0576522A4 (en) 1994-06-01
ATE194910T1 (de) 2000-08-15
EP0576522B1 (de) 2000-07-26
EP0576522A1 (de) 1994-01-05

Similar Documents

Publication Publication Date Title
DE69231291D1 (de) Impfsystem mit einer einzeldosis
AU611944B2 (en) Water insoluble polypeptides
ATE109000T1 (de) System zur freisetzung von medikamenten und dessen herstellungsmethode.
DE69229949D1 (de) Diltiazem enthaltende arzneimittel mit verzögerter wirkstoffabgabe
ATE225165T1 (de) Im unteren teil des verdauungstrakts freisetzende pharmazeutische zubereitung in form einer beschichteten kapsel
MY113488A (en) Compounds with growth hormone releasing properties
DE69519685D1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
IL84167A (en) Oral delivery of bioactive agents to and through the peyer's patch by use of microencapsulation
NO884474L (no) Implanterbart, biologisk nedbrytbart virkestoff-frigjoeringssystem.
EP0778047A3 (de) Intramuskuläre Stimulationsleitung mit Abwehreigenschaften gegen Infektionen
DE69530919D1 (de) Beigeordnetes polymersystem zur verwendung mit einer medizinischen vorrichtung
NZ221390A (en) Biodegradable implant containing estradiol and poly(lactide-co-glycolide) polymer: method of administration and preparation
DE69101710T2 (de) Arzneimittel freisetzendes polymeres system.
ATE69725T1 (de) Pharmazeutische zubereitungen von acrivastine.
NZ221575A (en) A microgranular preparation for intestinal delivery of biologically active materials in animals
CA2202499A1 (en) Renibacterium salmoninarum vaccine and method for its preparation
IL115138A0 (en) Implantable polymer-containing molded articles for the administration of active substances to plants and processes for the preparation thereof
IT8220758A1 (it) Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
US3796217A (en) Drug release system
CA2000932A1 (en) Oral pharmaceutical controlled release multiple unit dosage form
IE791966L (en) Microparticle drug delivery
CA2019779A1 (en) Intermittent release dosage form
DK0871467T3 (da) Ny formulering til afgivelse af peptid
CA2065847A1 (en) Rotavirus reassortant vaccine

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee